Pharmaceutical Preparations · DE · CIK 1477845
Annovis Bio develops buntanetap, a drug candidate to treat neurodegenerative diseases by inhibiting neurotoxic protein synthesis
Comparable business profile · signals at a glance
In the 90 days to Dec 8, 2025: 2 insiders bought $2.8M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 8, 2025 | Hoffman Michael BDirector | Buy | 30,000 | $4.34 | $130K |
| Dec 8, 2025 | Hoffman Michael BDirector | Buy | 15,000 | $4.24 | $64K |
| Nov 24, 2025 | Hoffman Michael BDirector | Buy | 28,096 | $4.15 | $117K |
| Nov 24, 2025 | Hoffman Michael BDirector | Buy | 28,096 | $4.15 | $117K |
| Nov 24, 2025 | Hoffman Michael BDirector | Buy | 9,200 | $3.85 | $35K |
| Nov 24, 2025 | Hoffman Michael BDirector | Buy | 9,200 | $3.85 | $35K |
| Nov 24, 2025 | Hoffman Michael BDirector | Buy | 1,489 | $4.13 | $6K |
| Nov 24, 2025 | Hoffman Michael BDirector | Buy | 1,489 | $4.13 | $6K |
| Nov 24, 2025 | Hoffman Michael BDirector | Buy | 415 | $4.14 | $2K |
| Nov 24, 2025 | Hoffman Michael BDirector | Buy | 415 | $4.14 | $2K |
| Nov 21, 2025 | Hoffman Michael BDirector | Buy | 10,000 | $3.50 | $35K |
| Nov 21, 2025 | Hoffman Michael BDirector | Buy | 10,000 | $3.49 | $35K |
| Nov 14, 2025 | Hoffman Michael BDirector | Buy | 15,000 | $2.11 | $32K |
| Oct 28, 2025 | Hoffman Michael BDirector | Buy | 975,610 | $2.05 | $2.0M |
| Oct 28, 2025 | Maccecchini Maria-LuisaPresident & CEO | Buy | 97,561 | $2.05 | $200K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.